Delgocitinib cream reduces itch and pain in adults with moderate to severe chronic hand eczema: pooled analyses of the phase 3 DELTA-1 and-2 trials

被引：0
|
作者：
Bauer, Andrea [1 ]
Schuttelaar, Marie-Louise [2 ]
Baranowski, Keith [3 ]
Plohberger, Ursula [3 ]
Sorensen, Laura [3 ]
Worm, Margitta [4 ]
机构：
[1] Tech Univ Dresden, Univ Allergy Ctr, Univ Hosp Carl Gustav Carus, Dept Dermatol, Dresden, Germany
[2] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands
[3] LEO Pharm A S, Ballerup, Denmark
[4] Charite Univ Med Berlin, Dept Dermatol Venerol & Allergy, Div Allergy & Immunol, Berlin, Germany
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷
关键词：
chronic hand eczema; delgocitinib; JAK;
D O I：
10.1093/bjd/ljae266.033
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
654
引用
收藏
页数：2
相关论文
共 49 条
  • [1] Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema: pooled results of the phase 3 DELTA-1 and-2 trials
    Bissonnette, Robert
    Worm, Margitta
    Warren, Richard B.
    Agner, Tove
    Gooderham, Melinda
    Schuttelaar, Marie Louise
    Baranowski, Keith
    Plohberger, Ursula
    Soerensen, Laura
    Schliemann, Sibylle
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [2] Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema: pooled results from the phase 3 DELTA-1 and-2 studies
    Bissonnette, R.
    Worm, M.
    Warren, R. B.
    Agner, T.
    Gooderham, M.
    Schuttelaar, M. L.
    Baranowski, K.
    Plohberger, U.
    Soerensen, L.
    Schliemann, S.
    ALLERGOLOGIE, 2024, 47 (09)
  • [3] Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, trials
    Bissonnette, Robert
    Warren, Richard B.
    Pinter, Andreas
    Agner, Tove
    Gooderham, Melinda
    Schuttelaar, Marie L. A.
    Crepy, Marie-Noelle
    Stingeni, Luca
    Serra-Baldrich, Esther
    Baranowski, Keith
    Korn, Sofie
    Kurvits, Merle
    Plohberger, Ursula
    Vest, Natacha Strange
    Schliemann, Sibylle
    LANCET, 2024, 404 (10451): : 461 - 473
  • [4] Systemic exposure and safety profile of delgocitinib cream in adults with moderate to severe chronic hand eczema in the phase 3 DELTA-2 trial
    Gooderham, Melinda
    Thaci, Diamant
    Damgaard, Tina
    Madsen, Daniel
    Soehoel, Anders
    Bissonnette, Robert
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [5] Treatment with delgocitinib cream improves itch, pain and other signs and symptoms of chronic hand eczema: Results from the Hand Eczema Symptom Diary in a phase IIb randomized clinical trial
    Bauer, Andrea
    Thyssen, Jacob P. P.
    Buhl, Timo
    Nielsen, Thor Schutt Svane
    Larsen, Lotte Seiding
    Osterskov, Anne Birk
    Agner, Tove
    CONTACT DERMATITIS, 2023, 89 (01) : 46 - 53
  • [6] THE IMPACT OF MODERATE TO SEVERE CHRONIC HAND ECZEMA AND THE EFFECT OF IMPROVED CLINICAL SYMPTOMS ON WORK PRODUCTIVITY LOSS: DATA FROM THE DELTA 1 AND DELTA 2 PHASE 3 TRIALS
    Bauer, A.
    Halling, C.
    Korn, S.
    Nyholm, N.
    VALUE IN HEALTH, 2023, 26 (12) : S456 - S456
  • [7] Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with chronic hand eczema: results of the phase 3 open-label extension DELTA-3 trial
    Gooderham, Melinda
    Molin, Sonja
    Bissonnette, Robert
    Worm, Margitta
    Crepy, Marie-Noelle
    Stingeni, Luca
    Warren, Richard B.
    Schliemann, Sibylle
    Balita-Crisostomo, Cherry Lou
    Oesterdal, Marie Louise
    Agner, Tove
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 35 - 36
  • [8] Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis
    Leon Kircik
    Matthew Zirwas
    Shawn G. Kwatra
    G. Michael Lewitt
    Holly Glover
    Tomas Chao
    Philip M. Brown
    David S. Rubenstein
    Anna M. Tallman
    Dermatology and Therapy, 2024, 14 : 201 - 211
  • [9] Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis
    Kircik, Leon
    Zirwas, Matthew
    Kwatra, Shawn G.
    Lewitt, G. Michael
    Glover, Holly
    Chao, Tomas
    Brown, Philip M.
    Rubenstein, David S.
    Tallman, Anna M.
    DERMATOLOGY AND THERAPY, 2024, 14 (01) : 201 - 211
  • [10] Nemolizumab monotherapy improves itch, sleep disturbance, and skin lesions in patients with moderate-to-severe prurigo nodularis: Pooled analyses from OLYMPIA 1 and OLYMPIA 2 phase 3 studies
    Yosipovitch, Gil
    Staender, Sonja
    Metz, Martin
    Pink, Andrew E.
    Silverberg, Jonathan, I
    Sofen, Howard
    Ahmed, Faiz
    Noda, Aliene
    Lopez, Zarif K. Jabbar
    Piketty, Christophe
    Kwatra, Shawn G.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 47 - 48
12345